You just read:

Merz Pharma Canada, Ltd. Announces Health Canada Approval of XEOMIN® COSMETIC (Clostridium Botulinum Neurotoxin Type A (150kD), free from complexing proteins) for the Temporary Improvement in the Appearance of Moderate to Severe Glabellar Lines

News provided by

Merz Pharma Canada Ltd.

Apr 17, 2012, 08:02 ET